BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 16 July 2013 |
| Author/s |
author: Andrew Biankin Mark J. Cowley Julia Gee Cristin Print Rachael A McCloy Susan Clark |
| Publication date | July 16, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |